Impact of stroke-associated pneumonia on the outcome of acute ischemic stroke in internal carotid artery system
DOI: 10.32364/2587-6821-2020-4-9-539-543
D.T. Chipova1, L.V. Santikova2, A.Ch. Zhemukhov2
1City Clinical Hospital No. 1, Nalchik, Russian Federation
2Kabardino-Balkarian State University named after H.M. Berbekov, Nalchik, Russian Federation
Aim: to study the stroke-associated pneumonia (SAP) effect on the outcome of ischemic stroke (IS) in the internal carotid artery system.
Patients and Methods: 87 patients with IS underwent the follow-up study, of which 75 had no inflammatory bronchopulmonary complications (group 1), and 12 had pneumonia manifestation (group 2). The study was performed on days 1, 5, and 9 after IS, and 6 months and 12 months after discharge from the hospital. Neurological deficit severity (NIHSS, Barthel index) and inflammatory markers (peripheral blood leukocyte composition, C-reactive protein (CRP), ESR) were studied.
Results: it was found that the presence of SAP was associated with increased mortality during the acute IS period (4 (33.1%) patients died in group 1 and 10 (13.3%) — in group 2, p<0.05), greater severity of neurological deficits (63.3±5.3 and 71.5±4.0 points on the NIHSS scale, respectively, p<0.05) and incapacitation (Barthel index — 63.3±5.3 and 71.5±4.0 points, respectively, p<0.05) at the end of the inpatient treatment period. In group 2, signs of an inflammatory response were detected on day 5, and the values of the white blood cell shift index, ESR and CRP significantly (p<0.05) differed from the initial values. During examination at 6 months and 12 months, there were no significant differences in these indicators between the groups. An association was established between the probability of SAP occurrence and the presence of swallowing disorders (r=0.672; p<0.05), the age of patients (r=0.572; p<0.05) and the presence of diabetes mellitus (r=0.522; p<0.05). The studied laboratory inflammatory markers allow us to timely assume the occurrence of pulmonary pathology.
Conclusion: timely diagnosis and prevention of SAP can reduce the risk of fatal outcome, facilitate rehabilitation measures, and improve early IS outcomes.
Keywords: ischemic stroke, cardioembolic stroke, atherothrombotic stroke, complications, acute period, inflammatory markers, stroke-associated pneumonia, long-term outcomes.
For citation: Chipova D.T., Santikova L.V., Zhemukhov A.Ch. Impact of stroke-associated pneumonia on the outcome of acute ischemic stroke in internal carotid artery system. Russian Medical Inquiry. 2020;4(9):539–543. DOI: 10.32364/2587-6821-2020-4-9-539-543.
About the authors:
Dinara T. Chipova — Head of the Department of General Neurology of City Clinical Hospital No. 1: 7, Golovko str., Nalchik, 360000, Russian Federation; ORCID iD 0000-0002-1641-3681.
Liana V. Santikova — post-graduate student of the Department of Neurology, Psychiatry and Narcology, Kabardino-Balkarian State University named after H.M. Berbekov; 173, Chernyshevskogo str., Nalchik, 360004, Russian Federation; ORCID iD 0000-0002-3361-6819.
Aslan Ch. Zhemukhov — post-graduate student of the Department of Neurology, Psychiatry and Narcology, Kabardino-Balkarian State University named after H.M. Berbekov; 173, Chernyshevskogo str., Nalchik, 360004, Russian Federation; ORCID iD 0000-0002-8877-9965.
Contact information: Dinara T. Chipova, e-mail: dinara.chipova@mail.ru. Financial Disclosure: no authors have a financial or property interest in any material or method mentioned. There is no conflict of interests. Received 03.09.2020, revised 17.09.2020, accepted 01.10.2020.
2. Lopez A., Adair T. Is the long-term decline in cardiovascular disease mortality in high-income countries over? Evidence from national vital statistics. Int J Epidemiol. 2019;48:1815–1823. DOI: 10.1093/ije/dyz143.
3. Tong X., Yang Q., Ritchey M. et al. The Burden of Cerebrovascular Disease in the United States. Prev Chronic Dis. 2019;16(4): e52. DOI:: 10.5888/pcd16.180411.
4. Клочихина О.А., Стаховская Л.В., Полунина Е.А. и др. Эпидемиология и прогноз уровня заболеваемости и смертности от инсульта в разных возрастных группах по данным территориально-популяционного регистра. Журнал неврологии и психиатрии им. С.С. Корсакова. 2019;119(8):5–12. DOI: 10.17116/jnevro20191190825. [Klochihin O.A., Stakhovskaya L.V., Polunina E.A. et al. Epidemiology and prognosis of morbidity and mortality from stroke in different age groups according to the territorial population register. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(8):5–12 (in Russ.)]. DOI: 10.17116/jnevro20191190825.
5. Yafasova A., Fosbøl E.L., Christianse M.N. et al. Time trends in incidence, comorbidity, and mortality of ischemic stroke in Denmark, 1996–2016. Neurology. 2020;95(17): e2343–e2353. DOI: 10.1212/WNL.0000000000010647.
6. Chamorro A., Meisel A., Planas A. et al. The immunology of acute stroke. Nat Rev Neurol. 2012;8:401–410. DOI: 10.1038/nrneurol.2012.98.
7. Emsley H.C., Hopkins S.J. Acute ischaemic stroke and infection: recent and emerging concepts. Lancet Neurol. 2008;7:341–353. DOI: 10.1016/ S1474-4422 (08) 70061-9.
8. Li J., Zhang P., Wu S. et al. Stroke-related complications in large hemisphere infarction: incidence and influence on unfavorable outcome. Ther Adv Neurol Disord. 2019;12:1756286419873264. DOI: 10.1177/1756286419873264.
9. Westendorp W., Vermeij J., Zock E. The Preventive Antibiotics in Stroke Study (PASS): a pragmatic randomised open-label masked endpoint clinical trial. Lancet. 2015;385:1619–1526. DOI: 10.1016/S0140-6736 (14) 62456-9.
10. Hoffmann S., Harms H., Ulm L. et al. Stroke-induced immunodepression and dysphagia independently predict stroke-associated pneumonia — The PREDICT study. J Cereb Blood Flow Metab. 2017;37(12):3671–3682. DOI: 10.1177/0271678X16671964.
11. Worthmann H., Tryc A., Dirks M. et al. Lipopolysaccharide binding protein, interleukin-10, interleukin-6 and C-reactive protein blood levels in acute ischemic stroke patients with post-stroke infection. J Neuroinflamm. 2015;12:13. DOI: 10.1186/s12974-014-0231-2.
12. Евзельман М.А., Митяева Е.В., Лашхия Я.Б., Камчатнов П.Р. Острая церебральная ишемия и воспаление. Журнал неврологии и психиатрии им. С.С. Корсакова. 2019;119(12):73–80. DOI: 10.17116/jnevro201911912273. [Evzelman M.A., Mityaeva E.V., Lashkhia Ya.B., Kamchatnov P.R. Acute cerebral ischemia and inflammation. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(12):73–80 (in Russ.)]. DOI: 10.17116/jnevro201911912273.
13. Соловьева Э.Ю., Чипова Д.Т. От концепции окислительного стресса к модуляции клеточной сигнализации. Журнал неврологии и психиатрии им. C.C. Корсакова. 2015;115(8):105–111. DOI: 10.17116/jnevro201511581105-111. [Solovieva E. Yu., Chipova D.T. From the conception of "oxidizing stress" to the conception of «cell signaling modulation». S.S. Korsakov Journal of Neurology and Psychiatry. 2015;115(8):105-111 (in Russ.)]. DOI: 10.17116/jnevro201511581105-111.
14. Smith C., Kishore A., Vail A. et al. Diagnosis of Stroke-Associated Pneumonia Recommendations From the Pneumonia in Stroke Consensus Group. Stroke. 2015;46:2335–2340. DOI: 10.1161/STROKEAHA.115.009617.
15. Katzan I., Dawson N., Thomas C. et al. The cost of pneumonia after acute stroke. Neurology. 2007;68:1938–1943. DOI: 10.1212/01.wnl.0000263187.08969.45.
16. Teh W.H., Smith C.J., Barlas R.S. et al. Impact of stroke-associated pneumonia on mortality, length of hospitalization, and functional outcome. Acta Neurol Scand. 2018;138(4):293–300. DOI: 10.1111/ane.12956.
17. Евзельман М.А., Орлова А.Д., Лашхия Я.Б. и др. Прогностические маркеры исхода ишемического инсульта. Журнал неврологии и психиатрии им. С.С. Корсакова. 2018; 12 (2):49–53. DOI: 10.17116/jneuro201811812249. [Evzel’man M.A., Orlova A.D., Lashkhiya Ya.B. et al. Prognostic markers of ischemic stroke outcome. S.S. Korsakov Journal of Neurology and Psychiatry. 2018;12(2):49–53 (in Russ.)]. DOI: 10.17116/jneuro201811812249.
18. Suda S., Aoki J., Shimoyama T. et al. Stroke-associated infection independently predicts 3-month poor functional outcome and mortality. J Neurol. 2018;265(2):370–375. DOI: 10.1007/s00415-017-8714-6.
19. Popović N., Stefanović-Budimkić M., Mitrović N. et al. The frequency of poststroke infections and their impact on early stroke outcome. Stroke Cerebrovasc Dis. 2013;22(4):424–429. DOI: 10.1016/j.jstrokecerebrovasdis.2013.03.003.
20. Ortega S.B., Noorbhai I., Poinsatte K. et al. Stroke induces a rapid adaptive autoimmune response to novel neuronal antigens. Discov Med. 2015;19:381–392.
21. Elkind M.S.V., Boehme A.K., Smith C.J. et al. Infection as a Stroke risk factor and determinant of outcome after stroke. Stroke. 2020;51(10):3156–3168. DOI: 10.1161/STROKEAHA.120.030429.
22. Becker K.J., Zierath D., Kunze A. et al. The contribution of antibiotics, pneumonia and the immune response to stroke outcome. J Neuroimmunol. 2016;295–296:68–74. DOI: 10.1016/j.jneuroim.2016.04.005.
23. Doyle K.P., Buckwalter M.S. Immunological mechanisms in poststroke dementia. Curr Opin Neurol. 2020;33:30–36. DOI: 10.1097/WCO. 0000000000000783.
24. Vargas M., Horcajada J., Obach V. et al. Clinical consequences of infection in patients with acute stroke: is it prime time for further antibiotic trials? Stroke. 2006;37(2):461–465. DOI: 10.1161/01.STR.0000199138.73365.b3.
25. Liu L., Xiong X., Zhang Q. et al. The Efficacy of prophylactic antibiotics on post-stroke infections: an updated systematic review and meta-analysis. Sci Rep. 2016;6:36656. DOI: 10.1038/srep36656.
26. Wan J., Wang X., Zhen Y. et al. The predictive role of the neutrophil-lymphocyte ratio in the prognosis of adult patients with stroke. Neurosurg J. 2020;6:22. DOI: 10.1186/s41016-020-00201-5.
This work is licensed under a Creative Commons «Attribution» 4.0 License.
